在新西兰,2026年在工作场所发现的阿片类药物增加了35%. Opioid workplace drug detections in New Zealand rose 35% in 2026.

新西兰工作场所毒品检测数据显示,2026年第一季度阿片类药物发现量同比增加35%,是所有物质中最显著的增长. New Zealand workplace drug testing data reveals a 35% year-on-year increase in opioid detections in the first quarter of 2026, marking the most significant rise among all substances. 虽然整体药物阳性略有下降,但阿片类药物在11个地区扩大了,塔拉纳基,诺斯兰和奥克兰急剧上升. While overall drug positivity slightly declined, opioids expanded in 11 regions, with sharp spikes in Taranaki, Northland, and Auckland. 毒品仍高于以前的水平,大麻仍然是最常发现的药物,而安非他命类型的药物的数量在特定地区上升. Cocaine remained above previous levels, cannabis was still the most commonly detected, and amphetamine-type substances rose in specific areas. 工人安全局警告说,这些区域趋势需要有针对性的工作场所安全战略而不是统一的政策. TDDA warns these regional trends require targeted workplace safety strategies rather than uniform policies.